We generated neutralizing anti-H5N1 human monoclonal antibodies (mAbs) and tested their efficacy for prophylaxis and therapy in a murine model of infection.

• 1918年西班牙流感大流行期间，输入病人的血制剂进行治疗大大降低了流感死亡率。